AO-IFAB: Ankle Osteoarthritis

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Unknown status
CT.gov ID
NCT03157141
Collaborator
(none)
120
1
41
2.9

Study Details

Study Description

Brief Summary

Ankle osteoarthritis is a progressive degenerative joint disease that is characterized by severe pain, loss of autonomy, diminished health-related quality of life, functional disability and diminished physical ability to fulfill occupational duties of life in its end-stage. Current surgical treatments for ankle osteoarthritis are ankle arthrodesis and total ankle replacement. Despite the good pain relief provided by these procedures, patients are still experiencing post-operatively important functional limitations in their activities of the daily living which affect their independency and quality of life. In order to remain capable of performing primary activities of the daily living, those patients have to make functional compensatory adaptations in the ipsilateral adjacent joints that will cause additional degenerative joint disease in those joints.

Currently, the outcome of foot and ankle surgery is primarily based on clinical, radiographic and questionnaire outcomes. However, these outcome measures have been criticized for not being sensitive enough to detect clinically meaningful change in foot function. To tackle these shortcomings, an advanced clinical examination platform integrating pressure-force-kinematic measurement devices was developed and showed its clinical value for the detection of intrinsic foot mobility impairments. Surprisingly, up-to-now, no study has included this integrated use of three-dimensional multi-segment foot models, plantar pressure platform and a force platform to report on the functional outcome of an ankle arthrodesis or a total ankle replacement.

Therefore, a multi-centre study will be conducted with two foot & ankle surgery centres. Both centres are equipped with the same advanced clinical examination platform. It is believed that proposed approach has the potential to provide further insight in the true functional changes related to ankle arthrodesis and total ankle replacement. This may in turn result in improved rehabilitation, less risk for post-operative complications, earlier discharge and quicker resumption of normal activities of the daily living, which would make ankle arthrodesis and total ankle replacement more cost-efficient and could potentially affect thousands of patients each year. Therefore, the hypotheses of the present study are:

  • Hypothesis (H1): Subjects with an ankle arthrodesis require a greater reorganization of foot and lower limb kinematic and kinetic patterns to respond to mechanical requirements of level walking compared to subjects with a total ankle replacement.

  • Null hypothesis (H0): Subjects with an ankle arthrodesis do not require a greater reorganization of foot and lower limb kinematic and kinetic patterns to respond to mechanical requirements of level walking compared to subjects with a total ankle replacement.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Ankle arthrodesis
  • Procedure: Total ankle replacement

Study Design

Study Type:
Observational
Anticipated Enrollment :
120 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Ankle Osteoarthritis and Its Treatments : Impact on Foot & Ankle Biomechanics
Actual Study Start Date :
Jan 1, 2017
Anticipated Primary Completion Date :
Jun 1, 2019
Anticipated Study Completion Date :
Jun 1, 2020

Arms and Interventions

Arm Intervention/Treatment
Control group, CG

For the purpose of the study, forty subjects for each group will be recruited. The control group (CG group) (so-called healthy subjects) CG will be recruited following the recruitment of the AA group and of the TAR group, as a sex, age and BMI matched design will be pursued. Inclusion criteria for the CG group are no history of orthopaedic lower limb surgery and absence of any known neurological or systematic disease.

Total ankle replacement group (TAR group)

The number of AA and TAR subjects used in a majority of studies to analyze the functional repercussion of an ankle arthrodesis or a total ankle replacement varied between 10 and 35 subjects.

Procedure: Total ankle replacement
A two-component ankle prosthesis will be inserted using the surgeon's standard technique, which essentially involves an anterior approach to the ankle joint. Once the joint is exposed, talar and tibial surfaces will be prepared and the prosthesis will be implanted according to the prosthesis surgical technique and its instrumentation.

Ankle arthrodesis group (AA group)

The number of AA and TAR subjects used in a majority of studies to analyze the functional repercussion of an ankle arthrodesis or a total ankle replacement varied between 10 and 35 subjects

Procedure: Ankle arthrodesis
Ankle arthrodesis consists of fusioning the joint surfaces of the ankle. The procedure will consist of removing the diseased cartilage and subchondral bone until bleeding of the cancellous bone surfaces is revealed. The bone ends will be opposed in the most appropriate and stable position and stabilized with screws or plates.

Outcome Measures

Primary Outcome Measures

  1. Foot and lower limb kinematics (degrees). [change from baseline (preoperative) to 12 months post-operatively]

    The Rizzoli 3D multi-segment foot model and the Rizzoli 3D lower limb model will be used to calculate changes pre-and post-operative foot and lower limb kinematics during barefoot walking.

  2. Foot and lower limb kinematics (degrees). [change from baseline (preoperative) to 24 months post-operatively]

    The Rizzoli 3D multi-segment foot model and the Rizzoli 3D lower limb model will be used to calculate changes pre-and post-operative foot and lower limb kinematics during barefoot walking.

  3. Joint moments (N.m/kg) [Change from baseline (preoperative) to 12 months post-operatively]

    3D multisegment foot kinetic model will allow to quantify mechanical loading of intrinsic foot joints during barefoot walking.

  4. Joint moments (N.m/kg) [Change from baseline (preoperative) to 24 months post-operatively]

    3D multisegment foot kinetic model will allow to quantify mechanical loading of intrinsic foot joints during barefoot walking.

  5. Force-time impulses (N.s) [Change from baseline (preoperative) to 12 months post-operatively]

    Force-time impulse is used to evaluate the effectiveness of a treatment at a specific foot location

  6. Force-time impulses (N.s) [Change from baseline (preoperative) to 24 months post-operatively]

    Force-time impulse is used to evaluate the effectiveness of a treatment at a specific foot location

  7. Power (W/kg) [Change from baseline (preoperative) to 24 months post-operatively]

    3D multisegment foot kinetic model will allow to quantify mechanical loading of intrinsic foot joints during barefoot walking.

  8. Power (W/kg) [Change from baseline (preoperative) to 12 months post-operatively]

    3D multisegment foot kinetic model will allow to quantify mechanical loading of intrinsic foot joints during barefoot walking.

Secondary Outcome Measures

  1. Demographic data [pre-operatively]

  2. Mechanical axis of the foot and lower limb (degrees) [pre-operatively]

    The medical records of participants who are eligible for the study, will be reviewed by a member of the research team to collect the standardized weightbearing anteroposterior ankle Meary view and standardized weightbearing lateral foot (and ankle) view to measure the mechanical axis of the foot and lower limb

  3. Position of the ankle arthrodesis or of the ankle prosthesis (degrees) [Change from baseline (preoperative) to 12 months post-operatively]

    The medical records of participants who are eligible for the study, will be reviewed by a member of the research team to collect the standardized weightbearing anteroposterior ankle Méary view and standardized weightbearing lateral foot (and ankle) view to measure the position of the ankle arthrodesis and/or of the ankle prosthesis.

  4. Health-related quality of life (SF-36) [Change from baseline (preoperative) to 12 months post-operatively]

    The Short-Form-36 (Version two) (SF-36) questionnaire will be used to assess health-related quality of life. The SF-36 is a 36 question survey that measures eight health concepts most affected by disease and treatment. The eight health concepts can then be used to form two summary measures: physical health and mental health. The SF-36 has been extensively validated and is one of the most widely used instruments to measure health status. The SF-36 has sound reliability and validity

  5. Health-related quality of life (SF-36) [Change from baseline (preoperative) to 24 months post-operatively]

    The Short-Form-36 (Version two) (SF-36) questionnaire will be used to assess health-related quality of life. The SF-36 is a 36 question survey that measures eight health concepts most affected by disease and treatment. The eight health concepts can then be used to form two summary measures: physical health and mental health. The SF-36 has been extensively validated and is one of the most widely used instruments to measure health status. The SF-36 has sound reliability and validity.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • primary osteoarthritis

  • post-traumatic osteoarthritis with an aligned or partially reducible deformity of the ankle and/or hindfoot

Exclusion Criteria:
  • history of orthopaedic lower limb surgery except for the ankle

  • neuromuscular disorders

  • vascular insufficiency

  • significant skin conditions such as skin ulcers or skin grafts

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier Lyon-Sud Pierre-Bénite France 69495

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

  • Principal Investigator: Jean-Luc BESSE, Dr, Centre Hospitalier Lyon-Sud, 69495 Pierre-Bénite Cédex, France

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Hospices Civils de Lyon
ClinicalTrials.gov Identifier:
NCT03157141
Other Study ID Numbers:
  • 69HCL17_0223
First Posted:
May 17, 2017
Last Update Posted:
May 17, 2017
Last Verified:
May 1, 2017
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Hospices Civils de Lyon
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 17, 2017